Stromal cells and stem cells in clinical bone regeneration

Nature Reviews Endocrinology

Volumn 11, Issue 3, 2015, Pages 140-150

  Grayson, Warren L ^a   Bunnell, Bruce A ^b   Martin, Elizabeth ^b   Frazier, Trivia ^b   Hung, Ben P ^a   Gimble, Jeffrey M ^b  

^a Johns Hopkins University School of Medicine   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE CELL; BONE MARROW; BONE NECROSIS; BONE REGENERATION; CELL EXPANSION; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); DNA MODIFICATION; FEMUR HEAD; HISTORY OF MEDICINE; HUMAN; IN VITRO STUDY; MESENCHYMAL STROMA CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PSEUDARTHROSIS; REGENERATIVE MEDICINE; REVIEW; SKELETON; STEM CELL; STROMA CELL; TIBIA; VASCULARIZATION; ANIMAL; BONE DISEASES; BONE DISEASES, METABOLIC; PHYSIOLOGY; WOUND HEALING;

ANIMALS; BONE DISEASES; BONE DISEASES, METABOLIC; BONE REGENERATION; CLINICAL TRIALS AS TOPIC; HUMANS; MESENCHYMAL STROMAL CELLS; STROMAL CELLS; WOUND HEALING;

EID: 84923642772     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.234     Document Type: Review

References (171)

1. Raggatt, L. J., et al. Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification. Am. J. Pathol. 184, 3192-3204 (2014
2. Das, A., Segar, C. E., Hughley, B. B., Bowers, D. T. & Botchwey, E. A. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. Biomaterials 34, 9853-9862 (2013
3. Kuroda, R., et al. Clinical impact of circulating CD34-positive cells on bone regeneration and healing. Tissue Eng. Part B Rev. 20, 190-199 (2014
4. Hutton, D. L. & Grayson, W. L. Stem cell-based approaches to engineering vascularized bone. Curr. Opin. Chem. Eng. 3, 75-82 (2014
5. Neovius, E. & Engstrand, T. Craniofacial reconstruction with bone and biomaterials: review over the last 11 years. J. Plast. Reconstr. Aesthet. Surg. 63, 1615-1623 (2010
6. Casserbette, M., Murray, A. B., Closs, E. I., Erfle, V. & Schmidt, J. Bone-formation by osteoblast-like cells in a 3 dimensional cell-culture. Calcif. Tissue Int. 46, 46-56 (1990
7. Dupont, K. M., et al. Human stem cell delivery for treatment of large segmental bone defects. Proc. Natl Acad. Sci. USA 107, 3305-3310 (2010
8. Friedenstein, A. J. Precursor cells of mechanocytes. Int. Rev. Cytol. 47, 327-359 (1976
9. Friedenstein, A. J. & Lalykina, K. S. Thymus cells are inducible to osteogenesis. Eur. J. Immunol. 2, 602-603 (1972
10. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I. & Frolova, G. P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247 (1968
11. Owen, M. & Friedenstein, A. J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42-60 (1988
12. Ashton, B. A., et al. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin. Orthop. Relat. Res. 151, 294-307 (1980
13. Allen, T. D. & Dexter, T. M. Cellular interrelationships during in vitro granulopoiesis. Differentiation 6, 191-194 (1976
14. Dexter, T. M., Allen, T. D. & Lajtha, L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. 91, 335-344 (1977
15. Lanotte, M., Scott, D., Dexter, T. M. & Allen, T. D. Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro. J. Cell. Physiol. 111, 177-186 (1982
16. Hunt, P., et al. A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells. Cell 48, 997-1007 (1987
17. Pietrangeli, C. E., Hayashi, S. & Kincade, P. W. Stromal cell lines which support lymphocyte growth: characterization, sensitivity to radiation and responsiveness to growth factors. Eur. J. Immunol. 18, 863-872 (1988
18. Whitlock, C. A., Tidmarsh, G. F., Muller Sieburg, C. & Weissman, I. L. Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre B neoplasia-Associated molecule. Cell 48, 1009-1021 (1987
19. Namen, A. E., et Al. Stimulation of B Cell Progenitors by Cloned Murine Interleukin 7. Nature 333, 571-573 (1988
20. Lee, G., Namen, A. E., Gillis, S. & Kincade, P. W. Recombinant interleukin 7 supports the growth of normal B lymphocyte precursors. Curr. Top. Microbiol. Immunol. 141, 16-18 (1988
21. Paul, S. R., et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl Acad. Sci. USA 87, 7512-7516 (1990
22. Caplan, A. I. Mesenchymal stem cells. J. Orthop. Res. 9, 641-650 (1991
23. Wakitani, S., Saito, T. & Caplan, A. I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5 azacytidine. Muscle Nerve 18, 1417-1426 (1995
24. Haynesworth, S. E., Baber, M. A. & Caplan, A. I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69-80 (1992
25. Simmons, P. J. & Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO 1. Blood 78, 55-62 (1991
26. Dominici, M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006
27. Mendicino, M., Bailey, A. M., Wonnacott, K., Puri, R. K. & Bauer, S. R. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 14, 141-145 (2014
28. Lo Surdo, J. & Bauer, S. R. Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. Tissue Eng. Part C Methods 18, 877-889 (2012
29. Lo Surdo, J. L., Millis, B. A. & Bauer, S. R. Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells. Cytotherapy 15, 1527-1540 (2013
30. Mindaye, S. T., Ra, M., Lo Surdo, J., Bauer, S. R. & Alterman, M. A. Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells. J. Proteomics 78, 1-14 (2013
31. Mindaye, S. T., Ra, M., Lo Surdo, J. L., Bauer, S. R. & Alterman, M. A. Global proteomic signature of undifferentiated human bone marrow stromal cells: evidence for donor to donor proteome heterogeneity. Stem Cell Res. 11, 793-805 (2013
32. Bianco, P., et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35-42 (2013
33. Robey, P. G., Kuznetsov, S. A., Riminucci, M. & Bianco, P. Bone marrow stromal cell assays: in vitro and in vivo. Methods Mol. Biol. 1130, 279-293 (2014
34. Zuk, P. A., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211-228 (2001
35. De Coppi, P., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25, 100-106 (2007
36. Mitchell, K. E., et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21, 50-60 (2003
37. Troyer, D. L. & Weiss, M. L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26, 591-599 (2008
38. Gronthos, S., Mankani, M., Brahim, J., Robey, P. G. & Shi, S. Postnatal human dental pulp stem cells (DPSCS) in vitro and in vivo. Proc. Natl Acad. Sci. USA 97, 13625-13630 (2000
39. Usas, A. & Huard, J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 28, 5401-5406 (2007
40. Feisst, V., Brooks, A. E., Chen, C. J. & Dunbar, P. R. Characterization of mesenchymal progenitor cell populations directly derived from human dermis. Stem Cells Dev. 23, 631-642 (2014
41. Erices, A., Conget, P. & Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109, 235-242 (2000
42. Kern, S., Eichler, H., Stoeve, J., Kluter, H. & Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301 (2006
43. Qu-Petersen, Z., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157, 851-864 (2002
44. Zuk, P. A., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295 (2002
45. Gronthos, S., et al. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189, 54-63 (2001
46. Crisan, M., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313 (2008
47. Pachon-Pena, G., et al. Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles. J. Cell. Physiol. 226, 843-851 (2011
48. Bourin, P., et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15, 641-648 (2013
49. Halvorsen, Y. D., et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 7, 729-741 (2001
50. Hicok, K. C., et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng. 10, 371-380 (2004
51. Justesen, J., Pedersen, S. B., Stenderup, K. & Kassem, M. Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng. 10, 381-391 (2004
52. Mesimaki, K., et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int. J. Oral Maxillofac. Surg. 38, 201-209 (2009
53. Levi, B., et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS ONE 5, e11177 (2010
54. Sandor, G. K., et al. Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-Tissue defects. Stem Cells Transl Med. 3, 530-540 (2014
55. Levi, B., et al. Differences in osteogenic differentiation of adipose-derived stromal cells from murine, canine, and human sources in vitro and in vivo. Plast. Reconstr. Surg. 128, 373-386 (2011
56. de Girolamo, L., Sartori, M. F., Albisetti, W. & Brini, A. T. Osteogenic differentiation of human adipose-derived stem cells: comparison of two different inductive media. J. Tissue Eng. Regen. Med. 1, 154-157 (2007
57. Im, G. I., Shin, Y. W. & Lee, K. B. Do Adipose Tissue-derived Mesenchymal Stem Cells Have the Same Osteogenic and Chondrogenic Potential As Bone Marrow-derived Cells?. Osteoarthritis Cartilage 13, 845-853 (2005
58. Hayashi, O., Katsube, Y., Hirose, M., Ohgushi, H. & Ito, H. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif. Tissue Int. 82, 238-247 (2008
59. Wolff, J., et al. GMP-level adipose stem cells combined with computer-Aided manufacturing to reconstruct mandibular ameloblastoma resection defects: experience with three cases. Ann. Maxillofac. Surg. 3, 114-125 (2013
60. Eilertsen, K. J., Floyd, Z. & Gimble, J. M. The epigenetics of adult (somatic) stem cells. Crit. Rev. Eukaryot. Gene Expr. 18, 189-206 (2008
61. Li, H., et al. Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells. Stem Cells Transl Med. 2, 667-677 (2013
62. Usas, A., et al. Skeletal muscle-derived stem cells: implications for cell-mediated therapies. Medicina 47, 469-479 (2011
63. Gao, X., et al. Role of donor and host cells in muscle-derived stem cell-mediated bone repair: differentiation vs. paracrine effects. FASEB J. 28, 3792-3809 (2014
64. Studeny, M., et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl Cancer Inst. 96, 1593-1603 (2004
65. Katakowski, M., et al. Exosomes from marrow stromal cells expressing miR 146b inhibit glioma growth. Cancer Lett. 335, 201-204 (2013
66. Xin, H., et al. Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25, 1618-1626 (2007
67. Loebinger, M. R., Eddaoudi, A., Davies, D. & Janes, S. M. Mesenchymal stem cell delivery of trail can eliminate metastatic cancer. Cancer Res. 69, 4134-4142 (2009
68. Belmar-Lopez, C., et al. Tissue-derived mesenchymal stromal cells used as vehicles for anti-Tumor therapy exert different in vivo effects on migration capacity and tumor growth. BMC Med. 11, 139 (2013
69. Dwyer, R. M., et al. Mesenchymal stem cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells 29, 1149-1157 (2011
70. Shah, K. Mesenchymal stem cells engineered for cancer therapy. Adv. Drug Deliv. Rev. 64, 739-748 (2012
71. Zhao, J., et al. Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma. Nanotechnology 25, 5101-5101 (2014
72. Zhang, T., et al. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res. Ther. 4, 70 (2014
73. Luo, J., et al. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene 33, 2768-2778 (2013
74. Warnke, P. H., et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364, 766-770 (2004
75. Mesimaki, K., et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int. J. Oral Maxillofac. Surg. 38, 201-209 (2009
76. Sandor, G. K., et al. Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration. J. Oral Maxillofac. Surg. 71, 938-950 (2013
77. Lendeckel, S., et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J. Craniomaxillofac. Surg. 32, 370-373 (2004
78. Bose, S., Roy, M. & Bandyopadhyay, A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 30, 546-554 (2012
79. Shrivats, A. R., McDermott, M. C. & Hollinger, J. O. Bone tissue engineering: state of the union. Drug Discov. Today 19, 781-786 (2014
80. Bhumiratana, S. & Vunjak-Novakovic, G. Personalized human bone grafts for reconstructing head and face. Stem Cells Transl Med. 1, 64-69 (2012
81. Tevlin, R., et al. Biomaterials for craniofacial bone engineering. J. Dent. Res. 93, 1187-1195 (2014
82. Liebergall, M., et al. Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study. Mol. Ther. 21, 1631-1638 (2013
83. Gangji, V., De Maertelaer, V. & Hauzeur, J. P. Autologous bone marrow cell implantation in the treatment of non-Traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone 49, 1005-1009 (2011
84. Gangji, V., et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells-A pilot study. J. Bone Joint Surg. Am. 86-A, 1153-1160 (2004
85. Mao, Q., et al. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study. Bone 57, 509-516 (2013
86. Zhao, D., et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone 50, 325-330 (2012
87. Levi, B., et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS ONE 5, e11177 (2010
88. Levi, B., et al. Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects. Stem Cells 29, 1241-1255 (2011
89. Cowan, C. M., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat. Biotechnol. 22, 560-567 (2004
90. Boerckel, J. D., Uhrig, B. A., Willett, N. J., Huebsch, N. & Guldberg, R. E. Mechanical regulation of vascular growth and tissue regeneration in vivo. Proc. Natl Acad. Sci. USA 108, E674-E680 (2011
91. Caplan, A. I. & Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98, 1076-1084 (2006
92. Dong, F. & Caplan, A. I. Cell transplantation as an initiator of endogenous stem cell-based tissue repair. Curr. Opin. Organ Transplant. 17, 670-674 (2012
93. Eshkar-Oren, I., et al. The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf. Development 136, 1263-1272 (2009
94. Okuyama, H., et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J. Biol. Chem. 281, 15554-15563 (2006
95. Kubo, S., et al. Blocking vascular endothelial growth factor with soluble Flt 1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum. 60, 155-165 (2009
96. Reichert, J. C., et al. A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci. Transl Med. 4, 141ra93 (2012
97. Springer, I. N., et al. Bone graft versus BMP 7 in a critical size defect-cranioplasty in a growing infant model. Bone 37, 563-569 (2005
98. Wilson, S. M., et al. Adipose-derived mesenchymal stem cells enhance healing of mandibular defects in the ramus of swine. J. Oral Maxillofac. Surg. 70, E193-E203 (2012
99. Au, P., Tam, J., Fukumura, D. & Jain, R. K. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111, 4551-4558 (2008
100. Correia, C., et al. In vitro model of vascularized bone: synergizing vasculogenesis and osteogenesis. PLoS ONE 6, e28352 (2011
101. Correia, C., et al. Human adipose-derived cells can serve as a single-cell source for the in vitro cultivation of vascularized bone grafts. J. Tissue Eng. Regen. Med. 8, 629-639 (2012
102. Tsigkou, O., et al. Engineered vascularized bone grafts. Proc. Natl Acad. Sci. USA 107, 3311-3316 (2010
103. Rivron, N. C., et al. Sonic hedgehog-Activated engineered blood vessels enhance bone tissue formation. Proc. Natl Acad. Sci. USA 109, 4413-4418 (2012
104. Fuchs, S., Hofmann, A. & Kirkpatrick, C. J. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2 dimensional and 3 dimensional co-cultures with osteoblastic lineage cells. Tissue Eng. 13, 2577-2588 (2007
105. Martineau, L. & Doillon, C. J. Angiogenic response of endothelial cells seeded dispersed versus on beads in fibrin gels. Angiogenesis 10, 269-277 (2007
106. Laib, A. M., et al. Spheroid-based human endothelial cell microvessel formation in vivo. Nat. Protoc. 4, 1202-1215 (2009
107. Alajati, A., et al. Spheroid-based engineering of a human vasculature in mice. Nat. Methods 5, 439-445 (2008
108. Hutton, D. L., Moore, E. M., Gimble, J. & Grayson, W. L. Platelet-derived growth factor and spatiotemporal cues induce development of vascularized bone tissue by adipose-derived stem cells. Tissue Eng. Part A 19, 2076-2086 (2013
109. Mehta, M., Schmidt-Bleek, K., Duda, G. N. & Mooney, D. J. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv. Drug Deliv. Rev. 64, 1257-1276 (2012
110. Kaigler, D., Silva, E. A. & Mooney, D. J. Guided bone regeneration using injectable vascular endothelial growth factor delivery gel. J. Periodontol. 84, 230-238 (2013
111. Martino, M. M., et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl Med. 3, 100ra89 (2011
112. Shah, N. J., et al. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 32, 6183-6193 (2011
113. Shah, N. J., et al. Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings. Sci. Transl Med. 5, 191ra183 (2013
114. Spiess, B. D. Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J. Appl. Physiol. 106, 1444-1452 (2009
115. Kimelman-Bleich, N., et al. The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo. Biomaterials 30, 4639-4648 (2009
116. Kelly, B. D., et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ. Res. 93, 1074-1081 (2003
117. Bosch-Marce, M., et al. Effects of aging and hypoxia-inducible factor 1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ. Res. 101, 1310-1318 (2007
118. Wang, Y., et al. The hypoxia-inducible factor a pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 117, 1616-1626 (2007
119. Wang, Y., Wan, C., Gilbert, S. R. & Clemens, T. L. Oxygen sensing and osteogenesis. Ann. NY Acad. Sci. 1117, 1-11 (2007
120. Schipani, E., Maes, C., Carmeliet, G. & Semenza, G. L. Regulation of osteogenesis-Angiogenesis coupling by HIFs and VEGF. J. Bone Miner. Res. 24, 1347-1353 (2009
121. Hu, X., et al. Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning. Stem Cells 32, 2702-2713 (2014
122. Jiang, Q., et al. Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. J. Mol. Cell. Cardiol. 56, 1-7 (2013
123. Carlier, A., et al. Mosaic: a multiscale model of osteogenesis and sprouting angiogenesis with lateral inhibition of endothelial cells. PLoS Comput. Biol. 8, e10022724 (2012
124. Xie, C., et al. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng. 13, 435-445 (2007
125. Huang, C., Tang, M., Yehling, E. & Zhang, X. Overexpressing sonic hedgehog peptide restores periosteal bone formation in a murine bone allograft transplantation model. Mol. Ther. 22, 430-439 (2014
126. Rosen, V. Harnessing the parathyroid hormone, Wnt, and bone morphogenetic protein signaling cascades for successful bone tissue engineering. Tissue Eng. Part B Rev. 17, 475-479 (2011
127. Bleich, N. K., et al. Gene therapy approaches to regenerating bone. Adv. Drug Deliv. Rev. 64, 1320-1330 (2012
128. Hung., B. P., Babalola, O. M. & Bonassar, L. J. Quantitative characterization of mesenchymal stem cell adhesion to the articular cartilage surface. J. Biomed. Mater. Res. A. 101, 3592-3598 (2013
129. Vangsness, C. T., et al. Adult human mesenchymal stem cells delivered via intra-Articular injection to the knee following partial medial meniscectomy. J. Bone Joint Surg. Am. 96, 90-98 (2014
130. Sart, S., Tsai, A. C., Li, Y. & Ma, T. Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng. Part B 20, 365-380 (2014
131. Sart, S., Ma, T. & Li, Y. Preconditioning stem cells for in vivo delivery. Biores. Open Access 3, 137-149 (2014
132. Harrison, B. S., Eberli, D., Lee, S. J., Atala, A. & Yoo, J. J. Oxygen producing biomaterials for tissue regeneration. Biomaterials 28, 4628-4634 (2007
133. Oh, S. H., Ward, C. L., Atala, A., Yoo, J. J. & Harrison, B. S. Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials 30, 757-762 (2009
134. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00512434?term=NCT00512434&rank=1 (2013
135. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01206179?term=NCT01206179&rank=1 (2011
136. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01429012?term=NCT01429012&rank=1 (2013
137. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01788059?term=NCT01788059&rank=1 (2013
138. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00250302?term=NCT00250302&rank=1 (2011
139. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01435434?term=NCT01435434&rank=1 (2014
140. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT02177565?term=NCT02177565&rank=1 (2014
141. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01626625?term=NCT01626625&rank=1 (2012
142. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01842477?term=NCT01842477&rank=1 (2013
143. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01725698?term=NCT01725698&rank=1 (2012
144. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01958502?term=NCT01958502&rank=1 (2013
145. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT02065167?term=NCT02065167&rank=1 (2014
146. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01700920?term=NCT01700920&rank=1 (2012
147. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01544712?term=NCT01544712&rank=1 (2012
148. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01605383?term=NCT01605383&rank=1 (2014
149. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01210950?term=NCT01210950&rank=1 (2014
150. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01552707?term=NCT01552707&rank=1 (2014
151. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01389661?term=NCT01389661&rank=1 (2013
152. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01603836?term=NCT01603836&rank=1 (2012
153. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT02172885?term=NCT02172885&rank=1 (2014
154. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00186914?term=NCT00186914&rank=1 (2008
155. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00001391?term=NCT00001391&rank=1 (2010
156. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01207193?term=NCT01207193&rank=1 (2011
157. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00221130?term=NCT00221130&rank=1 (2009
158. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01532076?term=NCT01532076&rank=1 (2014
159. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT02140528?term=NCT02140528&rank=1 (2014
160. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01643655?term=NCT01643655&rank=1 (2014
161. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01501461?term=NCT01501461&rank=1 (2013
162. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01739504?term=NCT01739504&rank=1 (2014
163. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01585857?term=NCT01585857&rank=1 (2014
164. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01885819?term=NCT01885819&rank=1 (2014
165. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT02241408?term=NCT02241408&rank=1 (2014
166. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01885832?term=NCT01885832&rank=1 (2014
167. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT02142842?term=NCT02142842&rank=1 (2014
168. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01947348?term=NCT01947348&rank=1 (2014
169. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01633892?term=NCT01633892&rank=1 (2014
170. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01645722?term=NCT01645722&rank=1 (2014
171. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01218945?term=NCT01218945&rank=1 (2013